Why the study?
Do serum levels of IGFBP-2 and IGFBP-3 correlate with tumor markers in patients with epithelial ovarian cancer?
Population
20 patients with epithelial ovarian cancer, 10 patients with benign ovarian tumors, and 8 healthy…
Design
Case-control
Authors
Loading...
May support IGFBP-2 as adjunct marker in ovarian cancer; leaves open prospective validation before any clinical use.
Do serum levels of IGFBP-2 and IGFBP-3 correlate with tumor markers in patients with epithelial ovarian cancer?
Serum IGFBP-2 levels are elevated in epithelial ovarian cancer and correlate with CA 125, suggesting potential utility as an additional tumor marker.
Allan Flyvbjerg (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: